iPerf

iPerf, a medtech start-up created in 2021, has developed an innovative solution to prevent serious complications associated with cardiopulmonary assistance via extracorporeal circulations. The iPerf femoral arterial cannula was invented and designed by Professor Pierre Mordant, thoracic and vascular surgeon specialized in lung transplant at Hôpital Bichat in Paris (AP-HP). The innovation incorporates a dual-flow system that ensures optimal irrigation of the patient's upper body while preserving circulation to his leg, thus reducing the risk of ischemia and amputation, to improve the patient survival. Maya Bertron, CEO of the company, has built a team of six professionals with solid expertise, especially in R&D and Regulatory Affairs. A high-level Scientific Advisory Board supports iPerf. The company is completing the industrialization of its innovative device, and preparing its first clinical trial in Europe and access to the US market. iPerf has raised 7 million € in 2021-2023.